Systematic Financial Management LP Lannett CO Inc Transaction History

Systematic Financial Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.9 - $7.12 $215,208 - $312,710	-43,920 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$6.43 - $9.86 $69,926 - $107,227	-10,875 Reduced 19.85%	43,920 $319,000
Q1 2020 May 12, 2020	SELL	$6.36 - $10.05 $102,586 - $162,106	-16,130 Reduced 22.74%	54,795 $381,000
Q4 2019 Feb 14, 2020	BUY	$8.49 - $12.81 $602,153 - $908,549	70,925 New	70,925 $626,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.